Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Rekah Pharmaceutical Industry Ltd.
  6. News
  7. Summary
    REKA   IL0010810096

REKAH PHARMACEUTICAL INDUSTRY LTD.

(REKA)
  Report
SummaryChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Rekah Pharmaceutical Industry Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021

11/25/2021 | 04:12am EST

Rekah Pharmaceutical Industry Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was ILS 61.98 million compared to ILS 72.72 million a year ago. Net income was ILS 0.053 million compared to ILS 3.94 million a year ago. Basic earnings per share from continuing operations was ILS 0.01 compared to ILS 0.34 a year ago. Diluted earnings per share from continuing operations was ILS 0.01 compared to ILS 0.34 a year ago. For the nine months, sales was ILS 189.76 million compared to ILS 193.16 million a year ago. Net income was ILS 3.31 million compared to ILS 8.92 million a year ago. Basic earnings per share from continuing operations was ILS 0.29 compared to ILS 0.78 a year ago. Diluted earnings per share from continuing operations was ILS 0.29 compared to ILS 0.78 a year ago.


ę S&P Capital IQ 2021
All news about REKAH PHARMACEUTICAL INDUSTRY LTD.
2021Rekah Pharmaceutical Industry Ltd. Reports Earnings Results for the Third Quarter and N..
CI
2021Rekah Pharmaceutical Industry Ltd. Reports Earnings Results for the Second Quarter Ende..
CI
2021Rekah Pharmaceutical Industry Ltd. Reports Earnings Results for the Full Year Ended Dec..
CI
2020Be Drugstores Ltd., cancelled the acquisition of 51% stake in Bela Online Ltd., from Re..
CI
2019Be Drugstores Ltd., agreed to acquire 51% stake in Bela Online Ltd., from Rekah Pharmac..
CI
More news
Financials
Sales 2020 265 M 84,3 M 84,3 M
Net income 2020 10,8 M 3,43 M 3,43 M
Net Debt 2020 129 M 41,1 M 41,1 M
P/E ratio 2020 28,3x
Yield 2020 -
Capitalization 253 M 80,7 M 80,5 M
EV / Sales 2019 1,76x
EV / Sales 2020 1,64x
Nbr of Employees -
Free-Float 27,5%
Chart REKAH PHARMACEUTICAL INDUSTRY LTD.
Duration : Period :
Rekah Pharmaceutical Industry Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Mordechai Algrably Chief Executive Officer & Director
Yuval Bernshtein Chief Financial Officer
Avraham Bigger Chairman
Ehood Nisan Independent External Director
Arnon Zuaretz Independent External Director